Inventor · disambiguated record
Alfred Weber
Also filed as: DAHL HELMUT · EDER ULRICH · KENNECKE MARIO · WEBER ALFRED
66 granted patents·13 pending applications·450 citations·filing 1976–2024
99Inventor score
Top patents by PatentIndex Score
79 records- 0193US4179336AMicrobiological degradation of sterol side chains to a 17-keto groupSCHERING AG·Filed 1977·Granted Dec 18, 1979·41 cites·10 claims
- 0291US9084743B2Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereofTESCHNER WOLFGANG·Filed 2010·Granted Jul 21, 2015·32 cites·29 claims
- 0390US10738107B2Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggsBAXALTA INC·Filed 2016·Granted Aug 11, 2020·4 cites·11 claims
- 0489US9708391B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2016·Granted Jul 18, 2017·3 cites·20 claims
- 0589US8772462B2Removal of serine proteases by treatment with finely divided silicon dioxideTESCHNER WOLFGANG·Filed 2011·Granted Jul 8, 2014·5 cites·18 claims
- 0688US9468675B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2014·Granted Oct 18, 2016·4 cites·20 claims
- 0788US8921520B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXTER INT·Filed 2012·Granted Dec 30, 2014·3 cites·21 claims
- 0888US8785139B2Modification-dependent activity assaysWEBER ALFRED·Filed 2012·Granted Jul 22, 2014·15 cites·28 claims
- 0987US2024117009A1Removal of serine proteases by treatment with finely divided silicon dioxideTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1087US2024335549A1Therapeutic proteins with increased half-life and methods of preparing sameBAXALTA INC·Filed 2024·Application pending·0 cites
- 1186US4836510AMetallurgical plantVOEST ALPINE AG·Filed 1988·Granted Jun 6, 1989·39 cites·3 claims
- 1283US8114633B2Methods for differentiating plasma-derived protein from recombinant protein in a sampleWEBER ALFRED·Filed 2008·Granted Feb 14, 2012·7 cites·17 claims
- 1382US9075069B2Measurement of autoantibodies at low conductivity with increased sensitivityBAXTER INT·Filed 2012·Granted Jul 7, 2015·4 cites·26 claims
- 1482US8889838B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXTER INT·Filed 2013·Granted Nov 18, 2014·3 cites·21 claims
- 1580US9556261B2Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGsBAXALTA INC·Filed 2014·Granted Jan 31, 2017·3 cites·28 claims
- 1680US2022175939A1Therapeutic proteins with increased half-life and methods of preparing sameBAXALTA INC·Filed 2022·Application pending·0 cites
- 1777US8557534B2Method and compositions for specifically detecting physiologically acceptable polymer moleculesTURECEK PETER·Filed 2008·Granted Oct 15, 2013·4 cites·14 claims
- 1877US5163353AEnergy saving and monitoring pneumatic control valve systemROSS OPERATING VALVE CO·Filed 1991·Granted Nov 17, 1992·30 cites·46 claims
- 1976US11891431B2Removal of serine proteases by treatment with finely divided silicon dioxideTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Feb 6, 2024·0 cites·19 claims
- 2075US4100027AProcess for the preparation of 4-androstene-3,17-dione derivativesSCHERING AG·Filed 1976·Granted Jul 11, 1978·12 cites·10 claims
- 2173US12365723B2Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGSTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 22, 2025·0 cites·20 claims
- 2273US10875906B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2019·Granted Dec 29, 2020·0 cites·18 claims
- 2373US2021106691A1Therapeutic proteins with increased half-life and methods of preparing sameBAXALTA INC·Filed 2020·Application pending·0 cites
- 2472US9896501B2Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGsBAXALTA INC·Filed 2014·Granted Feb 20, 2018·1 cites·33 claims
- 2571US9547016B2Method and compositions for specifically detecting physiologically acceptable polymer moleculesBAXALTA INC·Filed 2013·Granted Jan 17, 2017·1 cites·20 claims
- 2671US4057541AMethod for isolation of 3-hydroxy steroids and 3-keto steroidsSCHERING AG·Filed 1976·Granted Nov 8, 1977·8 cites·9 claims
- 2770US8828676B2Methods for differentiating plasma-derived protein from recombinant protein in a sampleWEBER ALFRED·Filed 2011·Granted Sep 9, 2014·1 cites·14 claims
- 2869US5558142AWoodworking milling cutter particularly for grooving and profilingOERTLI WERKZEUGE AG·Filed 1995·Granted Sep 24, 1996·38 cites·7 claims
- 2969US4224320ANovel steroids of the pregnane series, substituted in the 17-position, their manufacture and their useSCHERING AG·Filed 1979·Granted Sep 23, 1980·8 cites·27 claims
- 3067US11999798B2Anti-factor IX padua antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jun 4, 2024·0 cites·20 claims
- 3167US10208106B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2017·Granted Feb 19, 2019·0 cites·18 claims
- 3267US4212940AProcess for the preparation of 21-hydroxy-20-methylpregnane derivativesSCHERING AG·Filed 1978·Granted Jul 15, 1980·6 cites·10 claims
- 3365US2019142958A1Therapeutic proteins with increased half-life and methods of preparing sameBAXALTA INC·Filed 2018·Application pending·0 cites
- 3465US2018318432A1Therapeutic proteins with increased half-life and methods of preparing sameBAXALTA INC·Filed 2018·Application pending·0 cites
- 3564US9512172B2Ethanol dependence of alpha1 antitrypsin C-terminal Lys truncation by basic carboxypeptidasesBAXALTA INC·Filed 2014·Granted Dec 6, 2016·0 cites·19 claims
- 3663US5238484APlant for the production of molten metals and methodVOEST ALPINE INDUSTRIANLAGENBA·Filed 1991·Granted Aug 24, 1993·26 cites·22 claims
- 3761US5100782AProcess for the preparation of l-amino acids and amino acid amidesSCHERING AG·Filed 1989·Granted Mar 31, 1992·10 cites·4 claims
- 3860US2017227557A1Method and compositions for specifically detecting physiologically acceptable polymer moleculesBAXALTA INC·Filed 2017·Application pending·0 cites
- 3960US2012329127A1Therapeutic proteins with increased half-life and methods of preparing sameSIEKMANN JUERGEN·Filed 2012·Application pending·0 cites
- 4059US8772240B2Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidasesMATTHIESSEN PETER·Filed 2007·Granted Jul 8, 2014·0 cites·11 claims
- 4158US6307032B1Highly purified factor VIII complexBAXTER AG·Filed 1997·Granted Oct 23, 2001·15 cites·29 claims
- 4257US4971698AProcess for wastewater purificationSCHERING AG·Filed 1989·Granted Nov 20, 1990·21 cites·3 claims
- 4357US4170518AMicrobiological conversion of sterol derivatives to 5-androsten-17-one derivatives and their useSCHERING AG·Filed 1976·Granted Oct 9, 1979·4 cites·10 claims
- 4455US9274122B2Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)VARADI KATALIN·Filed 2009·Granted Mar 1, 2016·0 cites·19 claims
- 4554US11098132B2Anti-factor IX Padua antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Aug 24, 2021·0 cites·52 claims
- 4653US5418145AProcess for the preparation of 4-androstene-3,17-dione and 1,4-androstadiene-3,17-dioneSCHERING AG·Filed 1993·Granted May 23, 1995·5 cites·2 claims
- 4753US4644067AProcess for the extraction of amino acids from an aqueous phaseSCHERING AG·Filed 1985·Granted Feb 17, 1987·4 cites·15 claims
- 4853US2010152115A1Detection of physiologically acceptable polymer molecules using near infrared spectroscopyBAXTER INT·Filed 2009·Application pending·0 cites
- 4952US2024353431A1Selective measurement of human factor viiiTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 5052US2022389479A1HEPARIN-INSENSITIVE ASSAY FOR FACTOR XIaTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Alfred Weber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →